Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
about
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcomeFirst-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.Treatment options for central nervous system lymphomas in immunocompetent patients.Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort.Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma.Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma GroupAdvantages of dose-dense methotrexate protocol for primary central nervous system lymphoma: comparison of two different protocols at a single institution.Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center.Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.High-dose methotrexate for elderly patients with primary CNS lymphoma.Recent advances in treatment of primary central nervous system lymphoma.Chemotherapy in newly diagnosed primary central nervous system lymphoma.Pathogenesis and management of primary CNS lymphoma.Primary CNS lymphoma: a clinician's guide.Management of elderly patients with primary central nervous system lymphoma.Primary central nervous system lymphoma: what a neurologist/neurosurgeon should know?Diagnosis and treatment of primary CNS lymphoma.Present and future treatment options for primary CNS lymphoma.Pemetrexed for primary central nervous system lymphoma in the elderly.Current and emerging pharmacotherapies for primary CNS lymphoma.Advances in the treatment of newly diagnosed primary central nervous system lymphomas.Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma.Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.O⁶-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment.
P2860
Q30457046-6B1F4C43-BC85-49BD-9EAB-2BFB32BDF681Q30896676-318CB331-7CF9-45F1-9866-32E719327BACQ33413754-D59EAE07-1331-425B-8CD4-A88D87858D09Q33416656-CDAFC553-FF5F-4F8F-97B2-BE0E7596CA57Q33510785-9B77D70D-E47E-4164-80CC-338883C6A8BEQ33906988-C42F20EF-3DB8-4CFF-A739-FFFAEF4632FAQ34190457-730FDB0B-4165-46E2-B4EE-33D844C12D33Q34753447-BBF9AD61-6B5A-46AB-81AD-ECF3C8490862Q35236072-D76FF40C-7156-4827-9793-7C58CCE4BCDBQ35869493-1F9721DD-7114-409B-8EB5-ABA91CFB49E0Q35959919-10F82DFF-2660-43E4-8952-3AEA126D8D92Q36261369-EBA83B07-8F24-4508-88CC-F5C9610504DFQ36712741-90708740-A329-4675-8BD1-9A688CD771C5Q37256189-6D0237FD-CB1E-4B1F-8AF7-2FDFC6A190FAQ37345440-1C710117-DD1B-4339-B8A4-1AC737972535Q37905596-96CC8E00-A5AF-4551-8523-A3DAAB568984Q38010799-EB7FD837-3E1F-4D5F-AA08-BA35739949BAQ38053442-DD2D2494-1494-4E76-9E38-9E52A51ACD77Q38096927-1070CAC1-F118-4CC9-8B14-723C41D58897Q38099190-A5555BAD-3C52-4AB3-A343-C939AEAC4D13Q38106613-FD8A5196-4148-4B56-9126-9E0441C986D7Q38587122-8C50BC0D-F5C7-4165-85C2-4C342D09758AQ41591397-BB3F6FBC-EBE1-425C-836B-F0D1E4C65C29Q42126754-54EA2603-2CD3-46D0-850B-635692ACF414Q42377771-019FFDBF-4E23-48F2-BF60-7D4F977AEE34Q43241960-AB1E1C7F-BB08-496C-AED1-9E381E2329F0Q44981700-BCB178F1-A0B1-425E-9485-0AD9A063C05EQ48656685-BF4FC523-9974-41DA-B1E8-CFA07B88AADBQ49564968-CBE04884-B866-4B65-BBC0-FEAC32BEC188Q54345375-49131E81-76FE-4979-BC07-FA2101DB5CA9
P2860
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
@en
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
@nl
type
label
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
@en
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
@nl
prefLabel
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
@en
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
@nl
P2093
P1476
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
@en
P2093
Antonio M P Omuro
Charlotte Carnin
Khe Hoang-Xuan
Luc Taillandier
Maryline Barrie
Olivier Chinot
P2860
P2888
P304
P356
10.1007/S11060-007-9397-0
P577
2007-09-21T00:00:00Z